<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-RCH-08000179</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2008-09-04</date_registration>
      <primary_sponsor>Contagious Department of the first affiliated hospital of Zhejiang University, Hangzhou, China</primary_sponsor>
      <public_title>Correlation analysis of HCMV infection and hepatic transaminase after bone marrow hemopoietic stem cell transplantation surgery</public_title>
      <acronym />
      <scientific_title>Correlation analysis of HCMV infection and hepatic transaminase after bone marrow hemopoietic stem cell transplantation surgery</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2005-01-01</date_enrolment>
      <type_enrolment />
      <target_size>Infected group:10;No infection group:10;</target_size>
      <recruitment_status>Completed</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=9346</url>
      <study_type>Relative factors research</study_type>
      <study_design>Cohort study</study_design>
      <phase>I (Phase I study)</phase>
      <hc_freetext>HCMV infection after bone marrow transplantation surgery</hc_freetext>
      <i_freetext>Infected group:Ganciclovir administration for 8 days before transplantatioin (500mg / day, i.v.); Ganicclvir for 14days or until antigen negative conversion if there exists HCMV infection (500mg/day, ivgtt, bid).   ;No infection group:The patients were divided into infection or control group based on the difference of HCMV pp65 in peripheral blood.   ;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Hong Zhao</firstname>
        <middlename />
        <lastname />
        <address>Contagious Department of the first affiliated hospital of Zhe Jiang University, The national key laboratory of contagious diseases (18th floor, section A, 6th Building)</address>
        <city />
        <country1 />
        <zip>310003</zip>
        <telephone>+86 15858224023</telephone>
        <email>zhaohong0235@yahoo.com.cn</email>
        <affiliation>Zhejiang University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Weihang Ma</firstname>
        <middlename />
        <lastname />
        <address>Contagious Department of the first affiliated hospital of Zhe Jiang University, The national key laboratory of contagious diseases (18th floor, section A, No. 6 building)</address>
        <city />
        <country1 />
        <zip>310003</zip>
        <telephone>+86 15858224023</telephone>
        <email>maweihang@zju.edu.cn</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria for enrollment of patients were follow-up regularly more than 3 months after transplantation in our hospital and written informed consent.</inclusion_criteria>
      <agemin>0</agemin>
      <agemax>0</agemax>
      <gender>Both</gender>
      <exclusion_criteria>noneInclusion criteria for enrollment of patients were follow-up regularly more than 3 months after transplantation in our hospital and written informed consent.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Onset time of antigen, amounts of pp65 and IE;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>noneAge, sex;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The national natural science foundation, national 973 project</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2008-11-04</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>